| Year |
Citation |
Score |
| 2013 |
Sonsalla PK, Coleman C, Wong LY, Harris SL, Richardson JR, Gadad BS, Li W, German DC. The angiotensin converting enzyme inhibitor captopril protects nigrostriatal dopamine neurons in animal models of parkinsonism. Experimental Neurology. 250: 376-83. PMID 24184050 DOI: 10.1016/j.expneurol.2013.10.014 |
0.376 |
|
| 2013 |
Lee KW, Im JY, Woo JM, Grosso H, Kim YS, Cristovao AC, Sonsalla PK, Schuster DS, Jalbut MM, Fernandez JR, Voronkov M, Junn E, Braithwaite SP, Stock JB, Mouradian MM. Neuroprotective and anti-inflammatory properties of a coffee component in the MPTP model of Parkinson's disease. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 10: 143-53. PMID 23296837 DOI: 10.1007/S13311-012-0165-2 |
0.329 |
|
| 2012 |
Sonsalla PK, Wong LY, Harris SL, Richardson JR, Khobahy I, Li W, Gadad BS, German DC. Delayed caffeine treatment prevents nigral dopamine neuron loss in a progressive rat model of Parkinson's disease. Experimental Neurology. 234: 482-7. PMID 22309831 DOI: 10.1016/j.expneurol.2012.01.022 |
0.361 |
|
| 2012 |
Lee KW, Zhao X, Im JY, Grosso H, Jang WH, Chan TW, Sonsalla PK, German DC, Ichijo H, Junn E, Mouradian MM. Apoptosis signal-regulating kinase 1 mediates MPTP toxicity and regulates glial activation. Plos One. 7: e29935. PMID 22253830 DOI: 10.1371/journal.pone.0029935 |
0.393 |
|
| 2010 |
Sonsalla PK, Wong LY, Winnik B, Buckley B. The antiepileptic drug zonisamide inhibits MAO-B and attenuates MPTP toxicity in mice: clinical relevance. Experimental Neurology. 221: 329-34. PMID 19948168 DOI: 10.1016/J.Expneurol.2009.11.018 |
0.34 |
|
| 2008 |
Sonsalla PK, Zeevalk GD, German DC. Chronic intraventricular administration of 1-methyl-4-phenylpyridinium as a progressive model of Parkinson's disease. Parkinsonism & Related Disorders. 14: S116-8. PMID 18583172 DOI: 10.1016/j.parkreldis.2008.04.008 |
0.307 |
|
| 2008 |
Rocha MA, Crockett DP, Wong LY, Richardson JR, Sonsalla PK. Na(+)/H(+) exchanger inhibition modifies dopamine neurotransmission during normal and metabolic stress conditions. Journal of Neurochemistry. 106: 231-43. PMID 18363831 DOI: 10.1111/j.1471-4159.2008.05355.x |
0.402 |
|
| 2007 |
Moy LY, Wang SP, Sonsalla PK. Mitochondrial stress-induced dopamine efflux and neuronal damage by malonate involves the dopamine transporter. The Journal of Pharmacology and Experimental Therapeutics. 320: 747-56. PMID 17090704 DOI: 10.1124/Jpet.106.110791 |
0.744 |
|
| 2007 |
Zeevalk GD, Manzino L, Sonsalla PK, Bernard LP. Characterization of intracellular elevation of glutathione (GSH) with glutathione monoethyl ester and GSH in brain and neuronal cultures: Relevance to Parkinson's disease Experimental Neurology. 203: 512-520. PMID 17049515 DOI: 10.1016/j.expneurol.2006.09.004 |
0.352 |
|
| 2006 |
Yazdani U, German DC, Liang CL, Manzino L, Sonsalla PK, Zeevalk GD. Rat model of Parkinson's disease: chronic central delivery of 1-methyl-4-phenylpyridinium (MPP+). Experimental Neurology. 200: 172-83. PMID 16546169 DOI: 10.1016/j.expneurol.2006.02.002 |
0.315 |
|
| 2003 |
Alfinito PD, Wang SP, Manzino L, Rijhsinghani S, Zeevalk GD, Sonsalla PK. Adenosinergic protection of dopaminergic and GABAergic neurons against mitochondrial inhibition through receptors located in the substantia nigra and striatum, respectively. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 10982-7. PMID 14645494 DOI: 10.1523/Jneurosci.23-34-10982.2003 |
0.502 |
|
| 2002 |
Chen JF, Steyn S, Staal R, Petzer JP, Xu K, Van Der Schyf CJ, Castagnoli K, Sonsalla PK, Castagnoli N, Schwarzschild MA. 8-(3-Chlorostyryl)caffeine may attenuate MPTP neurotoxicity through dual actions of monoamine oxidase inhibition and A2A receptor antagonism. The Journal of Biological Chemistry. 277: 36040-4. PMID 12130655 DOI: 10.1074/Jbc.M206830200 |
0.708 |
|
| 2002 |
Zeevalk GD, Manzino L, Sonsalla PK. Protection of malonate-induced GABA but not dopamine loss by GABA transporter blockade in rat striatum. Experimental Neurology. 176: 193-202. PMID 12093096 DOI: 10.1006/Exnr.2002.7917 |
0.377 |
|
| 2001 |
Gluck MR, Moy LY, Jayatilleke E, Hogan KA, Manzino L, Sonsalla PK. Parallel increases in lipid and protein oxidative markers in several mouse brain regions after methamphetamine treatment. Journal of Neurochemistry. 79: 152-60. PMID 11595767 DOI: 10.1046/J.1471-4159.2001.00549.X |
0.698 |
|
| 2001 |
Zeevalk GD, Bernard LP, Manzino L, Sonsalla PK. Differential sensitivity of mesencephalic neurons to inhibition of phosphatase 2A Journal of Pharmacology and Experimental Therapeutics. 298: 925-933. PMID 11504786 |
0.37 |
|
| 2001 |
Staal RG, Yang JM, Hait WN, Sonsalla PK. Interactions of 1-methyl-4-phenylpyridinium and other compounds with P-glycoprotein: relevance to toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Brain Research. 910: 116-25. PMID 11489261 DOI: 10.1016/S0006-8993(01)02674-9 |
0.694 |
|
| 2001 |
Chen JF, Xu K, Petzer JP, Staal R, Xu YH, Beilstein M, Sonsalla PK, Castagnoli K, Castagnoli N, Schwarzschild MA. Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21. PMID 11319241 |
0.335 |
|
| 2001 |
Chen J, Xu K, Petzer JP, Staal R, Xu Y, Beilstein M, Sonsalla PK, Castagnoli K, Castagnoli N, Schwarzschild MA. Neuroprotection by Caffeine and A2AAdenosine Receptor Inactivation in a Model of Parkinson's Disease The Journal of Neuroscience. 21: RC143-RC143. DOI: 10.1523/Jneurosci.21-10-J0001.2001 |
0.718 |
|
| 2000 |
German DC, Liang CL, Manaye KF, Lane K, Sonsalla PK. Pharmacological inactivation of the vesicular monoamine transporter can enhance 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of midbrain dopaminergic neurons, but not locus coeruleus noradrenergic neurons. Neuroscience. 101: 1063-9. PMID 11113355 DOI: 10.1016/S0306-4522(00)00385-7 |
0.353 |
|
| 2000 |
Hogan KA, Staal RG, Sonsalla PK. Analysis of VMAT2 binding after methamphetamine or MPTP treatment: disparity between homogenates and vesicle preparations. Journal of Neurochemistry. 74: 2217-20. PMID 10800969 DOI: 10.1046/J.1471-4159.2000.0742217.X |
0.719 |
|
| 2000 |
Staal RG, Sonsalla PK. Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata. The Journal of Pharmacology and Experimental Therapeutics. 293: 336-42. PMID 10773000 |
0.747 |
|
| 2000 |
Staal RG, Hogan KA, Liang CL, German DC, Sonsalla PK. In vitro studies of striatal vesicles containing the vesicular monoamine transporter (VMAT2): rat versus mouse differences in sequestration of 1-methyl-4-phenylpyridinium. The Journal of Pharmacology and Experimental Therapeutics. 293: 329-35. PMID 10772999 |
0.738 |
|
| 2000 |
Moy LY, Zeevalk GD, Sonsalla PK. Role for dopamine in malonate-induced damage in vivo in striatum and in vitro in mesencephalic cultures. Journal of Neurochemistry. 74: 1656-65. PMID 10737624 DOI: 10.1046/J.1471-4159.2000.0741656.X |
0.751 |
|
| 2000 |
Zeevalk GD, Manzino L, Sonsalla PK. NMDA receptors modulate dopamine loss due to energy impairment in the substantia nigra but not striatum Experimental Neurology. 161: 638-646. PMID 10686083 DOI: 10.1006/Exnr.1999.7283 |
0.491 |
|
| 1998 |
Sonsalla PK, Albers DS, Zeevalk GD. Role of glutamate in neurodegeneration of dopamine neurons in several animal models of parkinsonism Amino Acids. 14: 69-74. PMID 9871444 DOI: 10.1007/Bf01345245 |
0.501 |
|
| 1998 |
Moy LY, Albers DS, Sonsalla PK. Lowering ambient or core body temperature elevates striatal MPP+ levels and enhances toxicity to dopamine neurons in MPTP-treated mice. Brain Research. 790: 264-9. PMID 9593931 DOI: 10.1016/S0006-8993(98)00069-9 |
0.738 |
|
| 1997 |
Sonsalla PK, Manzino L, Sinton CM, Liang CL, German DC, Zeevalk GD. Inhibition of striatal energy metabolism produces cell loss in the ipsilateral substantia nigra. Brain Research. 773: 223-6. PMID 9409726 DOI: 10.1016/S0006-8993(97)00941-4 |
0.364 |
|
| 1997 |
Sanghera MK, Manaye K, McMahon A, Sonsalla PK, German DC. Dopamine transporter mRNA levels are high in midbrain neurons vulnerable to MPTP. Neuroreport. 8: 3327-31. PMID 9351666 DOI: 10.1097/00001756-199710200-00027 |
0.398 |
|
| 1997 |
Teng L, Crooks PA, Sonsalla PK, Dwoskin LP. Lobeline and nicotine evoke [3H]overflow from rat striatal slices preloaded with [3H]dopamine: differential inhibition of synaptosomal and vesicular [3H]dopamine uptake. The Journal of Pharmacology and Experimental Therapeutics. 280: 1432-44. PMID 9067333 |
0.326 |
|
| 1997 |
Zeevalk GD, Manzino L, Hoppe J, Sonsalla P. In vivo vulnerability of dopamine neurons to inhibition of energy metabolism European Journal of Pharmacology. 320: 111-119. PMID 9059843 DOI: 10.1016/S0014-2999(96)00892-8 |
0.491 |
|
| 1997 |
Zeevalk GD, Bernard LP, Albers DS, Mirochnitchenko O, Nicklas WJ, Sonsalla PK. Energy stress-induced dopamine loss in glutathione peroxidase- overexpressing transgenic mice and in glutathione-depleted mesencephalic cultures Journal of Neurochemistry. 68: 426-429. PMID 8978755 DOI: 10.1046/J.1471-4159.1997.68010426.X |
0.505 |
|
| 1997 |
Sonsalla PK, Albers DS, Zeevalk GD. Effect of glutamate on degeneration of dopamine neurons in several animal models of parkinsonism Amino Acids. 13: 54. |
0.354 |
|
| 1996 |
Liang CL, Sinton CM, Sonsalla PK, German DC. Midbrain dopaminergic neurons in the mouse that contain calbindin-D28k exhibit reduced vulnerability to MPTP-induced neurodegeneration. Neurodegeneration : a Journal For Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration. 5: 313-8. PMID 9117542 DOI: 10.1006/neur.1996.0042 |
0.356 |
|
| 1996 |
German DC, Nelson EL, Liang CL, Speciale SG, Sinton CM, Sonsalla PK. The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse. Neurodegeneration : a Journal For Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration. 5: 299-312. PMID 9117541 DOI: 10.1006/Neur.1996.0041 |
0.365 |
|
| 1996 |
Sonsalla PK, Jochnowitz ND, Zeevalk GD, Oostveen JA, Hall ED. Treatment of mice with methamphetamine produces cell loss in the substantia nigra. Brain Research. 738: 172-5. PMID 8949944 DOI: 10.1016/0006-8993(96)00995-X |
0.446 |
|
| 1996 |
Albers DS, Zeevalk GD, Sonsalla PK. Damage to dopaminergic nerve terminals in mice by combined treatment of intrastriatal malonate with systemic methamphetamine or MPTP Brain Research. 718: 217-220. PMID 8773791 DOI: 10.1016/0006-8993(96)00135-7 |
0.502 |
|
| 1995 |
Albers DS, Sonsalla PK. Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: Pharmacological profile of protective and nonprotective agents Journal of Pharmacology and Experimental Therapeutics. 275: 1104-1114. PMID 8531070 |
0.398 |
|
| 1995 |
Sonsalla PK. The role of N-methyl-d-aspartate receptors in dopaminergic neuropathology produced by the amphetamines Drug and Alcohol Dependence. 37: 101-105. PMID 7758399 DOI: 10.1016/0376-8716(94)01064-R |
0.372 |
|
| 1994 |
Delle Donne KT, Sonsalla PK. Protection against methamphetamine-induced neurotoxicity to neostriatal dopaminergic neurons by adenosine receptor activation Journal of Pharmacology and Experimental Therapeutics. 271: 1320-1326. PMID 7996441 |
0.342 |
|
| 1994 |
Giovanni A, Sonsalla PK, Heikkila RE. Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine. Part 2: Central administration of 1- methyl-4-phenylpyridinium Journal of Pharmacology and Experimental Therapeutics. 270: 1008-1014. PMID 7932148 |
0.397 |
|
| 1994 |
Giovanni A, Sieber BA, Heikkila RE, Sonsalla PK. Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine. Part 1: Systemic administration Journal of Pharmacology and Experimental Therapeutics. 270: 1000-1007. PMID 7932147 |
0.427 |
|
| 1994 |
Terleckyj I, Sonsalla PK. The sigma receptor ligand (±)-BMY 14802 prevents methamphetamine-induced dopaminergic neurotoxicity via interactions at dopamine receptors Journal of Pharmacology and Experimental Therapeutics. 269: 44-50. PMID 7513362 |
0.316 |
|
| 1992 |
SONSALLA PK, GIOVANNI A, SIEBER B‐, DONNE KD, MANZINO L. Characteristics of Dopaminergic Neurotoxicity Produced by MPTP and Methamphetamine Annals of the New York Academy of Sciences. 648: 229-238. PMID 1637048 DOI: 10.1111/j.1749-6632.1992.tb24542.x |
0.357 |
|
| 1992 |
Sonsalla PK, Zeevalk GD, Manzino L, Giovanni A, Nicklas WJ. MK-801 fails to protect against the dopaminergic neuropathology produced by systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice or intranigral 1-methyl-4-phenylpyridinium in rats Journal of Neurochemistry. 58: 1979-1982. PMID 1560247 DOI: 10.1111/j.1471-4159.1992.tb10081.x |
0.379 |
|
| 1992 |
German DC, Manaye KF, Sonsalla PK, Brooks BA. Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: sparing of calbindin-D28k-containing cells. Annals of the New York Academy of Sciences. 648: 42-62. PMID 1353337 DOI: 10.1111/j.1749-6632.1992.tb24523.x |
0.321 |
|
| 1991 |
Sonsalla PK, Riordan DE, Heikkila RE. Competitive and noncompetitive antagonists at N-methyl-D-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice Journal of Pharmacology and Experimental Therapeutics. 256: 506-512. PMID 1671596 |
0.35 |
|
| 1989 |
Manaye KF, Sonsalla PK, Barnett G, Heikkila RE, Woodward DJ, Smith WK, German DC. 1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'CH3-MPTP)-induced degeneration of mesostriatal dopaminergic neurons in the mouse: biochemical and neuroanatomical studies. Brain Research. 491: 307-15. PMID 2765888 DOI: 10.1016/0006-8993(89)90065-6 |
0.348 |
|
| 1989 |
Heikkila RE, Sieber BA, Manzino L, Sonsalla PK. Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse Molecular and Chemical Neuropathology. 10: 171-183. PMID 2669769 DOI: 10.1007/Bf03159727 |
0.459 |
|
| 1989 |
Sonsalla PK, Nicklas WJ, Heikkila RE. Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity Science. 243: 398-400. PMID 2563176 DOI: 10.1126/Science.2563176 |
0.415 |
|
| 1988 |
Heikkila RE, Youngster SK, Panek DU, Giovanni A, Sonsalla PK. Studies with the neurotoxicant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and several of its analogs Toxicology. 49: 493-501. PMID 3259742 DOI: 10.1016/0300-483X(88)90035-2 |
0.403 |
|
| 1988 |
Heikkila RE, Kindt MV, Sonsalla PK, Giovanni A, Youngster SK, McKeown KA, Singer TP. Importance of monoamine oxidase A in the bioactivation of neurotoxic analogs of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proceedings of the National Academy of Sciences of the United States of America. 85: 6172-6. PMID 3137566 |
0.335 |
|
| 1988 |
Kindt MV, Youngster SK, Sonsalla PK, Duvoisin RC, Heikkila RE. Role for monoamine oxidase-A (MAO-A) in the bioactivation and nigrostriatal dopaminergic neurotoxicity of the MPTP analog, 2'Me-MPTP. European Journal of Pharmacology. 146: 313-8. PMID 3131149 DOI: 10.1016/0014-2999(88)90308-1 |
0.471 |
|
| 1987 |
Heikkila RE, Sonsalla PK. The use of the MPTP-treated mouse as an animal model of parkinsonism Canadian Journal of Neurological Sciences. 14: 436-440. PMID 3499967 |
0.394 |
|
| 1986 |
Sonsalla PK, Heikkila RE. The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice European Journal of Pharmacology. 129: 339-345. PMID 3490988 DOI: 10.1016/0014-2999(86)90444-9 |
0.42 |
|
| 1986 |
Youngster SK, Duvoisin RC, Hess A, Sonsalla PK, Kindt MV, Heikkila RE. 1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'-CH3-MPTP) is a more potent dopaminergic neurotoxin than MPTP in mice. European Journal of Pharmacology. 122: 283-7. PMID 3486770 DOI: 10.1016/0014-2999(86)90115-9 |
0.446 |
|
| 1986 |
Sonsalla PK, Gibb JW, Hanson GR. Roles of D1 and D2 dopamine receptor subtypes in mediating the methamphetamine-induced changes in monoamine systems Journal of Pharmacology and Experimental Therapeutics. 238: 932-937. PMID 2943891 |
0.31 |
|
| 1986 |
Sonsalla PK, Gibb JW, Hanson GR. Nigrostriatal dopamine actions on the D2 receptors mediate methamphetamine effects on the striatonigral substance P system Neuropharmacology. 25: 1221-1230. PMID 2432440 DOI: 10.1016/0028-3908(86)90139-5 |
0.364 |
|
| 1986 |
Kindt MV, Nicklas WJ, Sonsalla PK, Heikkila RE. Mitochondria and the neurotoxicity of MPTP Trends in Pharmacological Sciences. 7: 473-475. DOI: 10.1016/0165-6147(86)90426-8 |
0.332 |
|
| 1985 |
Schmidt CJ, Gehlert DR, Peat MA, Sonsalla PK, Hanson GR, Wamsley JK, Gibb JW. Studies on the mechanism of tolerance to methamphetamine Brain Research. 343: 305-313. PMID 2413961 DOI: 10.1016/0006-8993(85)90748-6 |
0.339 |
|
| 1985 |
Schmidt CJ, Ritter JK, Sonsalla PK, Hanson GR, Gibb JW. Role of dopamine in the neurotoxic effects of methamphetamine Journal of Pharmacology and Experimental Therapeutics. 233: 539-544. PMID 2409267 |
0.361 |
|
| Show low-probability matches. |